AI-generated analysis. Always verify with the original filing.
SBC Medical Group Holdings Incorporated reported FY 2025 net revenues of $173.6M, a 15.48% decrease from $205.4M in FY 2024. Despite the revenue decline, net income attributable to the company increased 9.38% to $51.0M, driven by a significant reduction in operating expenses (down 30.26% to $59.8M) and a $14.6M gain from other income, primarily from the redemption of life insurance policies. Gross profit was $127.3M with a gross margin of 73.32%. The company generated $24.7M in operating cash flow and ended the year with $163.8M in cash and cash equivalents. Key developments include a strategic $20M equity investment in OrangeTwist, an additional $20M share repurchase authorization, and the identification of continuing material weaknesses in internal controls over related party transactions and executive compensation.
Revenue
$173.6M
Net Income
$51.0M
Gross Margin
73.32%
Gross Profit
$127.3M
Operating Income
$67.5M
operating margin
38.87%